Literature DB >> 11352173

Characterizing biosecurity, health, and culling during dairy herd expansions.

M A Faust1, M L Kinsel, M A Kirkpatrick.   

Abstract

Our objectives were to investigate strategies for biosecurity, expansion, and culling for expanding dairy herds in the Upper Midwest. Eighteen dairies in Iowa and Wisconsin were visited, and dairy managers and veterinarians were interviewed to characterize five biosecurity practices, herd culling practices, vaccines administered, and ensuing disease status for the herds. The majority of herds that were interviewed failed to employ comprehensive biosecurity programs for incoming cattle. Nearly 60% of herds obtained cattle from sources for which it was difficult to document genetic backgrounds and health histories, fewer than half required health testing for incoming cattle, and approximately 50% quarantined new cattle on arrival. Despite high rates of vaccination for bovine viral diarrhea, all herd owners and managers indicated that herd biosecurity was compromised as a result of expansion. Half of the interviewed herds indicated that bovine viral diarrhea and papillomatous digital dermatitis were notable disease problems. Herds that obtained cattle with unknown backgrounds and health status experienced the largest number of diseases. Before expansion, the most frequently cited reasons for culling were reproductively unsound; low milk production; mastitis, poor udder health, and high SCC; during expansion, the strategic decision to cull cows for low milk production was used less often. In addition, the stochastic simulation model, DairyORACLE, was used to evaluate economic outcomes for several expansion alternatives. Five model scenarios studied were: base scenario (herd size was maintained) and four expansion scenarios--all paired combinations of heifer quality (high, low) and voluntary culling (implemented, not implemented). Culling for low milk production yielded an additional $23.29 annually (6-yr annuity) per cow, but on the basis of purchased replacements, no voluntary culling was most profitable. Purchasing high versus low quality replacement heifers for expansions returned an additional $113.54 annually ($681.24 total net present value) per heifer purchased. Many opportunities exist to improve cattle-related factors for dairy herd expansions, including the use of comprehensive biosecurity programs, realistic planning and budgeting for cattle purchases, and cost effective purchase and culling practices.

Entities:  

Mesh:

Year:  2001        PMID: 11352173     DOI: 10.3168/jds.S0022-0302(01)74554-7

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  6 in total

Review 1.  Invited review: The role of contagious disease in udder health.

Authors:  H W Barkema; M J Green; A J Bradley; R N Zadoks
Journal:  J Dairy Sci       Date:  2009-10       Impact factor: 4.034

2.  Risk factors associated with animal mortality in pasture-based, seasonal-calving dairy and beef herds.

Authors:  S C Ring; J McCarthy; M M Kelleher; M L Doherty; D P Berry
Journal:  J Anim Sci       Date:  2018-02-15       Impact factor: 3.159

3.  Longitudinal Prevalence of Antibodies to Endemic Pathogens in Bulk Tank Milk Samples From Dairy Herds Engaged or Not in Contract Heifer Rearing.

Authors:  Marie-Claire McCarthy; Luke O'Grady; Connor G McAloon; John F Mee
Journal:  Front Vet Sci       Date:  2021-11-25

4.  Cattle producers' perceptions of biosecurity.

Authors:  Marnie L Brennan; Robert M Christley
Journal:  BMC Vet Res       Date:  2013-04-10       Impact factor: 2.741

Review 5.  Bioexclusion of diseases from dairy and beef farms: risks of introducing infectious agents and risk reduction strategies.

Authors:  John F Mee; Tim Geraghty; Ronan O'Neill; Simon J More
Journal:  Vet J       Date:  2012-10-26       Impact factor: 2.688

Review 6.  Biosecurity and risk management for dairy replacements.

Authors:  Fiona Maunsell; G Arthur Donovan
Journal:  Vet Clin North Am Food Anim Pract       Date:  2008-03       Impact factor: 3.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.